These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11814780)

  • 21. Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.
    Hodgetts KJ; Ge P; Yoon T; De Lombaert S; Brodbeck R; Gulianello M; Kieltyka A; Horvath RF; Kehne JH; Krause JE; Maynard GD; Hoffman D; Lee Y; Fung L; Doller D
    J Med Chem; 2011 Jun; 54(12):4187-206. PubMed ID: 21618986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in development of imidazo[1,2-a]pyrazines: synthesis, reactivity and their biological applications.
    Goel R; Luxami V; Paul K
    Org Biomol Chem; 2015 Mar; 13(12):3525-55. PubMed ID: 25563506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
    Hartz RA; Ahuja VT; Rafalski M; Schmitz WD; Brenner AB; Denhart DJ; Ditta JL; Deskus JA; Yue EW; Arvanitis AG; Lelas S; Li YW; Molski TF; Wong H; Grace JE; Lentz KA; Li J; Lodge NJ; Zaczek R; Combs AP; Olson RE; Mattson RJ; Bronson JJ; Macor JE
    J Med Chem; 2009 Jul; 52(14):4161-72. PubMed ID: 19552436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists.
    Huang CQ; Grigoriadis DE; Liu Z; McCarthy JR; Ramphal J; Webb T; Whitten JP; Xie MY; Chen C
    Bioorg Med Chem Lett; 2004 May; 14(9):2083-6. PubMed ID: 15080983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands.
    Arvanitis AG; Rescinito JT; Arnold CR; Wilde RG; Fitzgerald LW; Zaczek R; Hartig PR; Grossman S; Arneric SP; Gilligan PJ; Olson RE; Robertson DW
    Bioorg Med Chem Lett; 2003 Jan; 13(1):129-31. PubMed ID: 12467632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Coate HR; Cooke A; Dong H; Feng L; Foreman K; Rosenfeld-Franklin M; Honda A; Mak G; Mulvihill KM; Nigro AI; O'Connor M; Pirrit C; Steinig AG; Siu K; Stolz KM; Sun Y; Tavares PA; Yao Y; Gibson NW
    Bioorg Med Chem; 2008 Feb; 16(3):1359-75. PubMed ID: 17983756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series].
    Bonnet PA; Vitse O; Bénezech V; Subra G; Fabréguettes JR; Zanik L; Laurent F; Michel A; Bompart J; Chapat JP
    Ann Pharm Fr; 1998; 56(4):155-9. PubMed ID: 9770008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF
    Hartz RA; Vrudhula VM; Ahuja VT; Grace JE; Lodge NJ; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1360-1363. PubMed ID: 28223020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.
    Contour-Galéra MO; Poitout L; Moinet C; Morgan B; Gordon T; Roubert P; Thurieau C
    Bioorg Med Chem Lett; 2001 Mar; 11(5):741-5. PubMed ID: 11266182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
    Meng Z; Ciavarri JP; McRiner A; Zhao Y; Zhao L; Reddy PA; Zhang X; Fischmann TO; Whitehurst C; Arshad Siddiqui M
    Bioorg Med Chem Lett; 2013 May; 23(10):2863-7. PubMed ID: 23587425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the Suzuki reaction for the synthesis of aryl-substituted heterocycles as corticotropin-releasing hormone (CRH) antagonists.
    Cocuzza AJ; Chidester DR; Culp S; Fitzgerald L; Gilligan P
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1063-6. PubMed ID: 10230641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists.
    Cocuzza AJ; Hobbs FW; Arnold CR; Chidester DR; Yarem JA; Culp S; Fitzgerald L; Gilligan PJ
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1057-62. PubMed ID: 10230640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, binding studies, and structure-activity relationships of 1-aryl-and 2-aryl[1]benzopyranopyrazol-4-ones, central benzodiazepine receptor ligands.
    Colotta V; Cecchi L; Filacchioni G; Melani F; Palazzino G; Martini C; Giannaccini G; Lucacchini A
    J Med Chem; 1988 Jan; 31(1):1-3. PubMed ID: 2826782
    [No Abstract]   [Full Text] [Related]  

  • 35. Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex of control or chronically stressed rats.
    Murphy EK; Sved AF; Finlay JM
    Neuroscience; 2003; 116(4):1081-7. PubMed ID: 12617949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands.
    Arvanitis AG; Rescinito JT; Arnold CR; Wilde RG; Cain GA; Sun JH; Yan JS; Teleha CA; Fitzgerald LW; McElroy J; Zaczek R; Hartig PR; Grossman S; Arneric SP; Gilligan PJ; Olson RE; Robertson DW
    Bioorg Med Chem Lett; 2003 Jan; 13(1):125-8. PubMed ID: 12467631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats.
    Gurkovskaya OV; Palamarchouk V; Smagin G; Goeders NE
    Synapse; 2005 Sep; 57(4):202-12. PubMed ID: 15986362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines.
    Meurer LC; Tolman RL; Chapin EW; Saperstein R; Vicario PP; Zrada MM; MacCoss M
    J Med Chem; 1992 Oct; 35(21):3845-57. PubMed ID: 1359141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity.
    Jones JH; Holtz WJ; Cragoe EJ
    J Med Chem; 1973 May; 16(5):537-42. PubMed ID: 4352334
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
    Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
    Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.